The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind, placebo-controlled trial of metformin in reducing progression among men on expectant management for low-risk prostate cancer: The MAST (Metformin Active Surveillance Trial) study.
 
Neil E. Fleshner
Employment - Lilly Medical
Leadership - POINT Biopharma; Verity Pharmaceuticals
Stock and Other Ownership Interests - POINT Biopharma; Verity Pharmaceuticals
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Sanofi (Inst); Spectracure (Inst)
 
Rui Miguel Bernardino
No Relationships to Disclose
 
Katherine Lajkosz
No Relationships to Disclose
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Jonathan Izawa
No Relationships to Disclose
 
Darrel Drachenberg
No Relationships to Disclose
 
Jeff W. Saranchuk
No Relationships to Disclose
 
Simon Tanguay
Honoraria - Merck; Tersera
Consulting or Advisory Role - Merck; Tersera
 
Ricardo A. Rendon
Stock and Other Ownership Interests - Myovant Sciences
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
 
Michael Leveridge
No Relationships to Disclose
 
Bobby Shayegan
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Knight Pharmaceuticals; Novartis; TerSera; Tolmar
 
Adrian Fairey
No Relationships to Disclose
 
Jessica Grace Cockburn
No Relationships to Disclose
 
Doron Berlin
No Relationships to Disclose
 
Robert James Hamilton
Honoraria - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
 
Tiiu Sildva
No Relationships to Disclose
 
Rodney H. Breau
Honoraria - Astellas Pharma; Eisai; Knight Therapeutics; Merck; Tersera; Tersera; Tolmar
Research Funding - Tolmar
 
Patrick O. Richard
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Tolmar
Consulting or Advisory Role - Astellas Pharma; Bayer; Novartis
Travel, Accommodations, Expenses - Bayer
 
Laurence Klotz
Honoraria - Amgen; Bayer; Exact Imaging; Ferring; Profound Medical; Sanofi
Consulting or Advisory Role - Astellas Pharma; Sanofi
Research Funding - Exact Imaging; Ferring
Patents, Royalties, Other Intellectual Property - KVR pharma
Travel, Accommodations, Expenses - TerSera
 
Anthony M. Joshua
Stock and Other Ownership Interests - Opthea; Pricilium Therapeutics
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Grey Wolf Therapeutics (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Medison (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Starpharma (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods